10 unknown. 10 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Unknown 10 |
| Phase 1 | 2 | Unknown 2 |
| Phase 3 | 2 | Unknown 2 |
Follow MDS: new trials by email Literature Review of MDS trials Research Report on MDS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies Venetoclax plus RIC - Leukemia, Myeloid, Acute, MDS | Phase 2 | Unknown | Xianmin Song, MD | 50 | 2022-11-01 | 2023-11-28 |
| Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS BST-236 - AML, Adult, MDS | Phase 2 | Unknown | BioSight Ltd. | 40 | 2021-11-14 | 2023-03-09 |
| Hetrombopag for Low/Intermediate-1 Risk MDS With Thrombocytopenia Hetrombopag, Stanozolol Tablets - MDS | Phase 2 / Phase 3 | Unknown | Peking Union Medical College Hospital | 50 | 2021-10-01 | 2021-09-24 |
| Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS Azacitidine, all trans retinoic acid - AML, MDS | Phase 2 / Phase 3 | Unknown | The First Affiliated Hospital of Soochow University | 180 | 2021-05-01 | 2022-01-03 |
| A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS APG-115, 5-azacitidine - AML, Acute Myeloid Leukemia | Phase 1 / Phase 2 | Unknown | Ascentage Pharma Group Inc. | 69 | 2020-12-04 | 2024-02-01 |
| Chidamide Plus PTCy/Cyclosporine to Prevent GVHD After Myeloablative Conditioning, Matched PBSCT Chidamide, Cyclophosphamide, cyclosporine A - Leukemia, Acute, MDS | Phase 2 | Unknown | Sichuan University | 50 | 2019-01-01 | 2018-07-18 |
| A Study of Combined Deferasirox, Vitamin D and Azacytidine in High Risk MDS Deferasirox, Vitamin D and Azacitidine - MDS | Phase 1 / Phase 2 | Unknown | Groupe Francophone des Myelodysplasies | 50 | 2013-02-01 | 2018-01-10 |
| ClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDS Clofarabine, ara-C, FLAMSA - Acute Myeloid Leukemia, MDS | Phase 2 | Unknown | Hannover Medical School | 60 | 2011-07-01 | 2011-08-29 |
| Best Promising Drug Association With Azacitidine in Higher Risk Myelodysplastic Syndromes Azacitidine, Azacitidine associated with Valproic acid, Azacitidine associated with Lenalidomide - MDS | Phase 2 | Unknown | Assistance Publique - Hôpitaux de Paris | 320 | 2011-06-01 | 2019-02-19 |
| Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI) fludarabine phosphate, busulfan - AML, MDS | Phase 2 | Unknown | Samsung Medical Center | 114 | 2008-08-01 | 2008-12-30 |
Leukemia, Myeloid, Acute (5) · Myelodysplastic Syndromes (2) · Frailty (1) · Hematologic Neoplasms (1) · Leukemia (1) · Leukemia, Myelomonocytic, Chronic (1) · Lymphoma (1) · Recurrence (1)
Hemic and Lymphatic Diseases (7) · Neoplasms (7) · Neoplasms by Histologic Type (7) · Hematologic Diseases (6) · Leukemia (5) · Leukemia, Myeloid (5) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Bone Marrow Diseases (2) · Disease Attributes (2) · Chronic Disease (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1)
Azacitidine (4) · Busulfan (1) · Clofarabine (1) · Cyclophosphamide (1) · Cyclosporine (1) · Cytarabine (1) · Deferasirox (1) · HBI-8000 (1) · Idarubicin (1) · Lenalidomide (1) · N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide (1) · Stanozolol (1) · Tretinoin (1) · Valproic Acid (1) · Vitamin D (1)
Ascentage Pharma Group Inc. (1) · Assistance Publique - Hôpitaux de Paris (1) · BioSight Ltd. (1) · Groupe Francophone des Myelodysplasies (1) · Hannover Medical School (1) · Peking Union Medical College Hospital (1) · Samsung Medical Center (1) · Sichuan University (1) · The First Affiliated Hospital of Soochow University (1) · Xianmin Song, MD (1)
China (4) · France (2) · United States (2) · Belgium (1) · Germany (1) · South Korea (1)
Arnold Ganser, Prof. Dr. (1) · Bing Han, Docter (1) · Dong Hwan Kim (1) · Felipe Suarez, MD (1) · Han Yue, Ph.D (1) · Olivier Hermine, MD (1) · Pierre Fenaux, MD (1) · Pierre Fenaux, MD, PhD (1) · Ting Liu, MD (1) · Xianmin Song (1) · Yifan Zhai, MD, PhD (1)